Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Derek J. Fiterman"'
Autor:
Anil K. Sood, Kapil Mehta, Gabriel Lopez-Berestein, Robert L. Coleman, Michael T. Deavers, Pablo E. Vivas-Mejia, Derek J. Fiterman, Alpa M. Nick, Whitney A. Spannuth, William M. Merritt, Yvonne G. Lin, Jansina Y. Fok, Lingegowda S. Mangala, Jee Young Hwang
Tissue type transglutaminase (TG2) is a unique multifunctional protein that plays a role in many steps in the cancer metastatic cascade. Here, we examined the clinical (n = 93 epithelial ovarian cancers) and biological (in vitro adhesion, invasion, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0024de12222f1869e30bc55b880e2bef
https://doi.org/10.1158/0008-5472.c.6497622
https://doi.org/10.1158/0008-5472.c.6497622
Autor:
Anil K. Sood, Kapil Mehta, Gabriel Lopez-Berestein, Robert L. Coleman, Michael T. Deavers, Pablo E. Vivas-Mejia, Derek J. Fiterman, Alpa M. Nick, Whitney A. Spannuth, William M. Merritt, Yvonne G. Lin, Jansina Y. Fok, Lingegowda S. Mangala, Jee Young Hwang
Supplementary Figure 1 from Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c71539f6ec5668e1c00a8251d0493a3
https://doi.org/10.1158/0008-5472.22374885
https://doi.org/10.1158/0008-5472.22374885
Autor:
Anil K. Sood, Kapil Mehta, Gabriel Lopez-Berestein, Robert L. Coleman, Michael T. Deavers, Pablo E. Vivas-Mejia, Derek J. Fiterman, Alpa M. Nick, Whitney A. Spannuth, William M. Merritt, Yvonne G. Lin, Jansina Y. Fok, Lingegowda S. Mangala, Jee Young Hwang
Supplementary Figure Legends 1-2 from Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8daf01c51af59ba5bea9f1c1bba4ff0c
https://doi.org/10.1158/0008-5472.22374879.v1
https://doi.org/10.1158/0008-5472.22374879.v1
Autor:
Anil K. Sood, Kapil Mehta, Gabriel Lopez-Berestein, Robert L. Coleman, Michael T. Deavers, Pablo E. Vivas-Mejia, Derek J. Fiterman, Alpa M. Nick, Whitney A. Spannuth, William M. Merritt, Yvonne G. Lin, Jansina Y. Fok, Lingegowda S. Mangala, Jee Young Hwang
Supplementary Figure 2 from Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4857560f47034f8b5f02dac4bce8ef33
https://doi.org/10.1158/0008-5472.22374882
https://doi.org/10.1158/0008-5472.22374882
Autor:
Anil K. Sood, Kapil Mehta, Gabriel Lopez-Berestein, Robert L. Coleman, Michael T. Deavers, Pablo E. Vivas-Mejia, Derek J. Fiterman, Alpa M. Nick, Whitney A. Spannuth, William M. Merritt, Yvonne G. Lin, Jansina Y. Fok, Lingegowda S. Mangala, Jee Young Hwang
Supplementary Table 2 from Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96128ca6c33786d3f72ce62d2031a1f5
https://doi.org/10.1158/0008-5472.22374873
https://doi.org/10.1158/0008-5472.22374873
Autor:
Anil K. Sood, Kapil Mehta, Gabriel Lopez-Berestein, Robert L. Coleman, Michael T. Deavers, Pablo E. Vivas-Mejia, Derek J. Fiterman, Alpa M. Nick, Whitney A. Spannuth, William M. Merritt, Yvonne G. Lin, Jansina Y. Fok, Lingegowda S. Mangala, Jee Young Hwang
Supplementary Table 3 from Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3714b683be705ec652002b92697973d7
https://doi.org/10.1158/0008-5472.22374870.v1
https://doi.org/10.1158/0008-5472.22374870.v1
Autor:
Robert L. Coleman, Yvonne G. Lin, Derek J. Fiterman, Jee Young Hwang, Kapil Mehta, William M. Merritt, Gabriel Lopez-Berestein, Whitney A. Spannuth, Jansina Y. Fok, Anil K. Sood, Michael T. Deavers, Alpa M. Nick, Lingegowda S. Mangala, Pablo E. Vivas-Mejia
Publikováno v:
Cancer Research. 68:5849-5858
Tissue type transglutaminase (TG2) is a unique multifunctional protein that plays a role in many steps in the cancer metastatic cascade. Here, we examined the clinical (n = 93 epithelial ovarian cancers) and biological (in vitro adhesion, invasion, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4924f4ec23136c3ef810cf09e180736e
https://doi.org/10.1158/0008-5472.can-07-6130
https://doi.org/10.1158/0008-5472.can-07-6130
Autor:
Roman Rouzier, Y Wu, Peter Wagner, V. Valero, Derek J. Fiterman, V Dunmire, W Zhang, Nour Sneige, Henry M. Kuerer, Gabriel N. Hortobagyi, Jeffrey S. Ross, James Stec, Banu Arun, Richard L. Theriault, Kenneth R. Hess, William Fraser Symmans, Mark Ayers, Lajos Pusztai, S K Anderson, Constance Albarracin
Publikováno v:
Endocrine-Related Cancer. 12:1059-1069
The pathogenesis of breast cancers that do not express estrogen receptors or Her-2/neu receptors (ER−/HER2− phenotype) is incompletely understood. We had observed markedly elevated gene expression of gamma-aminobutyric acid type A (GABAA) recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0f63d38f6ee2319967651ff4aefdf4b
https://doi.org/10.1677/erc.1.01051
https://doi.org/10.1677/erc.1.01051
Autor:
Curtis J. Oleschuk, Frank S. Guziec, Lynn J. Guziec, Asher Begleiter, Cielo Monterrosa, Derek J. Fiterman, Jeanne Fourie
Publikováno v:
Cancer Chemotherapy and Pharmacology. 49:101-110
Purpose: Bioreductive antitumor agents are an important class of anticancer drugs that include the clinically used drug, mitomycin C, and new agents such as EO9 and tirapazamine that have recently been tested in clinical trials. These agents require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354bb8df834a693a781b9d3a0e738b93
https://doi.org/10.1007/s00280-001-0395-1
https://doi.org/10.1007/s00280-001-0395-1
B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells
Autor:
Francisco J. Esteva, Li Zhang, Rita Nahta, Linda X.H. Yuan, W. Fraser Symmans, Derek J. Fiterman, Naoto T. Ueno
Publikováno v:
Molecular cancer therapeutics. 5(6)
The antiapoptotic protein Bcl-2 is overexpressed in a majority of breast cancers, and is associated with a diminished apoptotic response and resistance to various antitumor agents. Bcl-2 inhibition is currently being explored as a possible strategy f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae3947afb245d6df3abe156ac228a34
https://pubmed.ncbi.nlm.nih.gov/16818519
https://pubmed.ncbi.nlm.nih.gov/16818519